Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anthracycline-induced Cardiotoxicity”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07370506
What this trial is testing

Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients

Who this might be right for
Breast CancerDoxorubicin Induced Cardiomyopathy
Tanta University 36
Not applicableUnknownNCT01032278
What this trial is testing

Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)

Who this might be right for
Cardiac ToxicityUnspecified Adult Solid Tumor, Protocol Specific
M.D. Anderson Cancer Center 597
Testing effectiveness (Phase 2)UnknownNCT03785704
What this trial is testing

Clinical Study of Xinmailong Injection on Reducing Cardiovascular Toxicity in Adjuvant Chemotherapy in Breast Cancer

Who this might be right for
Breast NeoplasmsCardiac EventChemotherapeutic Toxicity
Peking Union Medical College 60
Not applicableUnknownNCT06331806
What this trial is testing

Myocardial Fibrosis Identification in Patients With Anthracycline-induced Cardiotoxicity

Who this might be right for
Cardiomyopathy Due to Drug
European Institute of Oncology 100
Large-scale testing (Phase 3)Study completedNCT03265574
What this trial is testing

PROACT: Can we Prevent Chemotherapy-related Heart Damage in Patients With Breast Cancer and Lymphoma?

Who this might be right for
Breast CancerNon Hodgkin Lymphoma
South Tees Hospitals NHS Foundation Trust 111
Not applicableLooking for participantsNCT05223413
What this trial is testing

REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs

Who this might be right for
Anthracycline-induced Cardiac ToxicityLymphoma
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III 608
Post-approval studies (Phase 4)Looking for participantsNCT06491680
What this trial is testing

Cardiotoxicity in Breast Cancer Patients

Who this might be right for
Breast Cancer
Helwan University 40
Not applicableLooking for participantsNCT05467111
What this trial is testing

Cardioprotective Effect of Acute Exercise in Breast Cancer Patients

Who this might be right for
Early-stage Breast Cancer
Technical University of Madrid 40
Not applicableUnknownNCT03155802
What this trial is testing

Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines

Who this might be right for
CardiotoxicityHeart FailureBreast Cancer+3 more
Stony Brook University 35
Not applicableNot Yet RecruitingNCT06881940
What this trial is testing

Cardiac Rehabilitation Program on the Prevention of Cardiotoxicity in Breast Cancer Patients Undergoing Treatment With Anthracyclines and/or Trastuzumab

Who this might be right for
Cancer Therapy-Related Cardiac Dysfunction
Instituto Nacional de Cardiologia Ignacio Chavez 284
Testing effectiveness (Phase 2)Study completedNCT01095926
What this trial is testing

Pharmacokinetic Study of Doxorubicin in Children With Cancer

Who this might be right for
Wilms TumorNeuroblastomaSoft Tissue Sarcoma+1 more
University Hospital Muenster 101
Not applicableActive Not RecruitingNCT03748550
What this trial is testing

Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2)

Who this might be right for
Cancer, BreastCardiotoxicityCardiovascular Diseases
Nova Scotia Health Authority 7
Testing effectiveness (Phase 2)Looking for participantsNCT03934905
What this trial is testing

Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction

Who this might be right for
Anthracycline Related Cardiotoxicity in Breast Cancer
Texas Tech University Health Sciences Center 70
Testing effectiveness (Phase 2)Looking for participantsNCT05732051
What this trial is testing

Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients

Who this might be right for
Breast CancerMetastatic Breast CancerCancer Therapy-Related Cardiac Dysfunction+2 more
University Hospital, Akershus 60
Large-scale testing (Phase 3)UnknownNCT05792293
What this trial is testing

Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity

Who this might be right for
Doxorubicin Induced Cardiomyopathy
Ain Shams University 100
Testing effectiveness (Phase 2)Study completedNCT06888505
What this trial is testing

Dapagliflozin to Prevent Anthracycline-Induced Cardiotoxicity

Who this might be right for
Anthracyclines-Induced CardiotoxicityCardiotoxicity
Hawler Medical University 90
Post-approval studies (Phase 4)Looking for participantsNCT05465031
What this trial is testing

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Who this might be right for
Breast CancerNeoplasm, BreastBreast Diseases+10 more
Silesian Centre for Heart Diseases 600
Not applicableLooking for participantsNCT06282796
What this trial is testing

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

Who this might be right for
Breast Cancer
First Hospital of China Medical University 600
Not applicableEnded earlyNCT00679874
What this trial is testing

Assessment of Cardiotoxicity After Chemotherapy for Breast Cancer by Cardio-vascular Magnetic Resonance (MR)

Who this might be right for
Breast Cancer
University of Calgary 66
Not applicableEnded earlyNCT00728429
What this trial is testing

Aerobic Exercise in Patients Receiving Chemotherapy for Cancer

Who this might be right for
Cardiac ToxicityChemotherapeutic Agent ToxicityUnspecified Adult Solid Tumor, Protocol Specific
Wake Forest University Health Sciences 1
Load More Results